A national quality incentive scheme to reduce antibiotic overuse in hospitals: evaluation of perceptions and impact | Zendy

Jasmin Islam | Zendy; Diane AshiruOredope | Zendy; Emma Budd | Zendy; Philip Howard | Zendy; A. Sarah Walker | Zendy; Susan Hopkins | Zendy; Martin Llewelyn | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A national quality incentive scheme to reduce antibiotic overuse in hospitals: evaluation of perceptions and impact

Author(s) -

Jasmin Islam,

Diane AshiruOredope,

Emma Budd,

Philip Howard,

A. Sarah Walker,

Susan Hopkins,

Martin Llewelyn

Publication year - 2018

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dky041

Subject(s) - piperacillin/tazobactam , antimicrobial stewardship , medicine , antibiotics , tazobactam , medical prescription , antibiotic resistance , piperacillin , incentive , antibiotic stewardship , emergency medicine , intensive care medicine , nursing , microbiology and biotechnology , genetics , imipenem , bacteria , economics , pseudomonas aeruginosa , biology , microeconomics

In 2016/2017, a financially linked antibiotic prescribing quality improvement initiative Commissioning for Quality and Innovation (AMR-CQUIN) was introduced across acute hospitals in England. This aimed for >1% reductions in DDDs/1000 admissions of total antibiotics, piperacillin/tazobactam and carbapenems compared with 2013/2014 and improved review of empirical antibiotic prescriptions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research